{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:19:39Z","timestamp":1775121579695,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"The Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF20OC0059465"],"award-info":[{"award-number":["NNF20OC0059465"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kirsten and Freddy Johansen\u2019s Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Graves\u2019 disease (GD) is the main cause of hyperthyroidism in women of the fertile age. In pregnant women, the disease should be carefully managed and controlled to prevent maternal and fetal complications. Observational studies provide evidence of the adverse effects of untreated hyperthyroidism in pregnancy and have in more recent years substantiated a risk of teratogenic side effects with the use of antithyroid drugs (ATDs). These findings have challenged the clinical recommendations regarding the choice of treatment when patients become pregnant. To extend observational findings and support future clinical practice, a systematic collection of detailed clinical data in and around pregnancy is needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>With the aim of collecting clinical and biochemical data, a Danish multicenter study entitled \u2018Pregnancy Investigations on Thyroid Disease\u2019 (PRETHYR) was initiated in 2021. We here describe the design and methodology of the first study part of PRETHYR. This part focuses on maternal hyperthyroidism and recruits female patients in Denmark with a past or present diagnosis of GD, who become pregnant, as well as women who are treated with ATDs in the pregnancy, irrespective of the underlying etiology. The women are included during clinical management from endocrine hospital departments in Denmark, and study participation includes patient questionnaires in pregnancy and postpartum as well as review of medical records from the mother and the child.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data collection was initiated on November 1, 2021 and covered all five Danish Regions from March 1, 2022. Consecutive study inclusion will continue, and we here report the first status of inclusion. As of November 1, 2022, a total of 62 women have been included in median pregnancy week 19 (interquartile range (IQR): 10\u201327) with a median maternal age of 31.4 years (IQR: 28.5\u201335.1). At inclusion, 26 women (41.9%) reported current use of thyroid medication; ATDs (n\u2009=\u200914), Levothyroxine (n\u2009=\u200912).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This report describes a newly established systematic and nationwide collection of detailed clinical data on pregnant women with hyperthyroidism and their offspring. Considering the course and relatively low prevalence of GD in pregnant women, such nationwide design is essential to establish a sufficiently large cohort.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13044-023-00154-8","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T11:02:59Z","timestamp":1681210979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hyperthyroidism in pregnancy: design and methodology of a Danish multicenter study"],"prefix":"10.1186","volume":"16","author":[{"given":"Nanna Maria Uldall","family":"Torp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge B\u00fclow","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Carl\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Scott","family":"Karmisholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Ebbeh\u00f8j","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Grove-Laugesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Heiberg","family":"Brix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen Joop","family":"Bonnema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bieke F.","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birte","family":"Nygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena Bjergved","family":"Sigurd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Klose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5se Krogh","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine Linding","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"issue":"5","key":"154_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1530\/EJE-10-1155","volume":"164","author":"A Carl\u00e9","year":"2011","unstructured":"Carl\u00e9 A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol. 2011;164(5):801\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"154_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 european thyroid association guideline for the management of graves\u2019 hyperthyroidism. Eur Thyroid J. 2018;7(4):167\u201386.","journal-title":"Eur Thyroid J"},{"issue":"3","key":"154_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 guidelines of the american thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the Postpartum. Thyroid. 2017;27(3):315\u201389.","journal-title":"Thyroid"},{"issue":"1","key":"154_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/thy.2010.0286","volume":"21","author":"S Bliddal","year":"2011","unstructured":"Bliddal S, Rasmussen \u00c3K, Sundberg K, Brocks V, Skovbo P, Feldt-Rasmussen U. Graves\u2019 Disease in two Pregnancies complicated by fetal goitrous hypothyroidism: successful in Utero Treatment with Levothyroxine. Thyroid. 2011;21(1):75\u201381.","journal-title":"Thyroid"},{"issue":"4","key":"154_CR5","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.beem.2020.101414","volume":"34","author":"SL Andersen","year":"2020","unstructured":"Andersen SL, Kn\u00f8sgaard L. Management of thyrotoxicosis during pregnancy. Best Pract Res Clin Endocrinol Metab. 2020;34(4):101414.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"154_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","volume":"1","author":"DS Cooper","year":"2013","unstructured":"Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1(3):238\u201349.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"154_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905\u201317.","journal-title":"N Engl J Med"},{"issue":"3","key":"154_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S2213-8587(20)30025-5","volume":"8","author":"TH Brix","year":"2020","unstructured":"Brix TH, Lund LC, Henriksen DP, Folkestad L, Bonnema SJ, Hallas J, et al. Methimazole and risk of acute pancreatitis. Lancet Diabetes Endocrinol. 2020;8(3):187\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"154_CR9","doi-asserted-by":"publisher","first-page":"e220031","DOI":"10.1530\/ETJ-22-0031","volume":"11","author":"J Karmisholt","year":"2022","unstructured":"Karmisholt J, Andersen SL, Bulow-Pedersen I, Krejbjerg A, Nygaard B, Carl\u00e9 A. Long-term methimazole therapy in Graves\u2019 hyperthyroidism and adverse reactions: a danish multicenter study. Eur Thyroid J. 2022;11(3):e220031.","journal-title":"Eur Thyroid J"},{"key":"154_CR10","doi-asserted-by":"crossref","unstructured":"Andersen SL, Andersen S. Antithyroid drugs and birth defects.Thyroid Res. 2020;13(11).","DOI":"10.1186\/s13044-020-00085-8"},{"key":"154_CR11","doi-asserted-by":"crossref","unstructured":"Laurberg P, Andersen SL. Antithyroid Drug Use in pregnancy and birth defects: why some Studies find clear Associations, and some Studies Report none. Thyroid. 2015 Nov;25(11):1185\u201390.","DOI":"10.1089\/thy.2015.0182"},{"issue":"10","key":"154_CR12","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1210\/jc.2014-1322","volume":"99","author":"T Watt","year":"2014","unstructured":"Watt T, Cramon P, Heged\u00fcs L, Bjorner JB, Bonnema SJ, Rasmussen \u00c3K, et al. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab. 2014;99(10):3708\u201317.","journal-title":"J Clin Endocrinol Metab"},{"key":"154_CR13","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"154_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"2","key":"154_CR15","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1530\/EC-20-0518","volume":"10","author":"SL Andersen","year":"2021","unstructured":"Andersen SL, Andersen S. Hyperthyroidism in pregnancy: evidence and hypothesis in fetal programming and development. Endocr Connect. 2021;10(2):R77\u201386.","journal-title":"Endocr Connect"},{"issue":"5499","key":"154_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0140-6736(00)82433-2","volume":"213","author":"H Gardiner-Hill","year":"1929","unstructured":"Gardiner-Hill H. Pregnancy complicating simple Goitre and Graves\u2019 Disease. Lancet. 1929;213(5499):120\u20134.","journal-title":"Lancet"},{"issue":"5","key":"154_CR17","doi-asserted-by":"publisher","first-page":"R261","DOI":"10.1530\/EJE-18-0678","volume":"179","author":"HB Burch","year":"2018","unstructured":"Burch HB, Cooper DS. Antithyroid drug therapy: 70 years later. Eur J Endocrinol. 2018;179(5):R261\u201374.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"154_CR18","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EJE-14-0135","volume":"171","author":"P Laurberg","year":"2014","unstructured":"Laurberg P, Andersen SL. Antithyroid drug use in early pregnancy and birth defects. Time windows of relative safety and high risk? Eur J Endocrinol. 2014;171(1):R13\u201320.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"154_CR19","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1210\/jc.2013-2831","volume":"98","author":"SL Andersen","year":"2013","unstructured":"Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a danish nationwide study. J Clin Endocrinol Metab. 2013;98(11):4373\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"154_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7326\/M17-1398","volume":"168","author":"GH Seo","year":"2018","unstructured":"Seo GH, Kim TH, Chung JH. Antithyroid drugs and congenital malformations: a nationwide korean cohort study. Ann Intern Med. 2018;168(6):405\u201313.","journal-title":"Ann Intern Med"},{"issue":"1","key":"154_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/thy.2018.0621","volume":"29","author":"SL Andersen","year":"2019","unstructured":"Andersen SL, Andersen S. Timing of Shift in Antithyroid Drug Therapy and Birth defects. Thyroid. 2019;29(1):155\u20136.","journal-title":"Thyroid"},{"issue":"5","key":"154_CR22","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/EJE-16-0410","volume":"175","author":"P Laurberg","year":"2016","unstructured":"Laurberg P, Andersen SL. ENDOCRINOLOGY IN PREGNANCY: pregnancy and the incidence, diagnosing and therapy of Graves\u2019 disease. Eur J Endocrinol. 2016;175(5):R219\u2013230.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"154_CR23","doi-asserted-by":"publisher","first-page":"e3705","DOI":"10.1210\/clinem\/dgac383","volume":"107","author":"NM Uldall Torp","year":"2022","unstructured":"Uldall Torp NM, Bruun NH, Christensen PA, Handberg A, Andersen S, Andersen SL. Thyrotropin receptor antibodies in early pregnancy. J Clin Endocrinol Metab. 2022;107(9):e3705\u201313.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"154_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","volume":"33","author":"M Bliddal","year":"2018","unstructured":"Bliddal M, Broe A, Potteg\u00e5rd A, Olsen J, Langhoff-Roos J. The danish Medical Birth Register. Eur J Epidemiol. 2018;33(1):27\u201336.","journal-title":"Eur J Epidemiol"},{"key":"154_CR25","unstructured":"Danmarks Statistik. Befolkningstal. https:\/\/statistikbanken.dk\/folk1a. Accessed 10-24-2022."}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-023-00154-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T08:21:46Z","timestamp":1681460506000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-023-00154-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["154"],"URL":"https:\/\/doi.org\/10.1186\/s13044-023-00154-8","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"assertion":[{"value":"19 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Committee on Health Research Ethics deemed the study exempt from review. All individuals studied provided informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"11"}}